← FDA Drug Approvals (Drugs@FDA)

LINAGLIPTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2025-11-03

Drug application

FDA Application #
ANDA208428
Application type
Abbreviated New Drug Application (Generic)
Brand name
LINAGLIPTIN
Generic name
Linagliptin
Active ingredients
LINAGLIPTIN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
DR REDDYS
First approval
2025-11-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown